What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

User: Guest

Document type:: Zeitschriftenaufsatz
Author(s):: Czobor, Pál ; Sebe, Barbara ; Acsai, Károly ; Barabássy, Ágota ; Laszlovszky, István ; Németh, György ; Furukawa, Toshi A. ; Leucht, Stefan
Title:: What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial
Keywords:: Psychiatry ; minimum clinically important difference ; negative symptoms ; schizophrenia ; MCID ; clinical trial ; cariprazine
Journal title:: Frontiers in Psychiatry
Year:: 2022
Journal volume:: 13
Fulltext / DOI:: doi:10.3389/fpsyt.2022.816339
Publisher:: Frontiers Media S.A.
E-ISSN:: 1664-0640
Date of publication:: 25.04.2022
CC license:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Occurrences: